TBRC's global immuno-oncology drugs market report brings focus into the competitive landscape and tactics of key players within the market.
LONDON, March 23, 2022 /PRNewswire/ -- Immuno-oncology drugs industry growth analysis shows that companies have increased their investment in immuno-oncology combination studies, more than 200 mechanisms being investigated as PD-(L)1 or CTLA-4 combination partners and immuno-oncology assets estimated to represent approximately half of top-ten company pipelines. Immunotherapy is one of the most active sectors for investors, with overall funding of USD 96.9B in 1.4K+ companies. Therefore, the increasing investment in immuno-oncology is expected to drive the growth of the immuno-oncology market.
The global immuno-oncology drugs market size is expected to grow from $60.32 billion in 2021 to $70.59 billion in 2022 at a compound annual growth rate (CAGR) of 17.0%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The immuno-oncology market is expected to reach $120.37 billion in 2026 at a CAGR of 14.3%.
Request a free sample of the Immuno-Oncology Drugs Market Report
Competitive Landscape Of The Global Immuno-Oncology Drugs Market
The global stem cell therapy market is concentrated characterized by the presence of global immuno-oncology drugs providers. The top ten competitors in the market made up to 96.84% of the total market in 2020. Major players in the market include F. Hoffmann-La Roche, Merck & Co, Bristol-Myers Squibb, Amgen Inc, and Johnson & Johnson.
Immuno-Oncology Drugs Market Trend - Increased Acquisition Activity
The focus areas for many companies in the immune-oncology drugs market have shifted to increasing acquisitions to enhance their market presence. Large players are buying small or midsized companies to acquire new capabilities, or gain access to new markets. Players are also acquiring competitors to curb competition and increase market share.
Key Strategies Within The Market
Player-adopted strategies in the immuno-oncology drugs market includes focus on developing and launching new combinational drug therapies, improving presence in the immuno-oncology market through strategic partnerships, strengthening immune-oncology business through product licensing and acquisitions, and evaluating and advancing new technologies to change the treatment models and offer efficacious therapies in the field of immuno-oncology by creating strategic alliances.
See more on the Immuno-Oncology Drugs Market Report
Check out similar market reports:
Interventional Oncology Devices Global Market Report 2022 - By Product (Embolization Devices, Ablation Devices, Support Devices), By Procedure (Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE) or Bland Embolization), By Cancer Type (Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types) - Market Size, Trends, And Global Forecast 2022-2026
Oncology Drugs Global Market Report 2022 - By Type (Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) - Market Size, Trends, And Global Forecast 2022-2026
Cellular Immunotherapy Global Market Report 2022 - By Therapy (Tumour-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumour, Lung Cancer) - Market Size, Trends, And Global Forecast 2022-2026
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/
logo: https://mma.prnewswire.com/media/1751581/tbrc_logo.jpg
